Cmed Technology Updates EDC System

June 2, 2021

Article

On the heels of its acquisition by AIXIAL, the CRO of ALTEN Group, Cmed Technology announced enhancements to encapsia, its advanced enterprise, cloud-based clinical data system. The updates address decentralized trials capabilities, including the ability to add images and files into encapsiaEDC to facilitate remote monitoring; ability of a user to ‘pin’ their favorite reports/visualizations for immediate access; options for clients collecting eSource data, and a new home visit option.

For more information, click here.

Related Content

FDA Inspections Face Continued Overhaul and Changes

October 13th 2023

Article

Agency will be reorganizing field force and compliance functions.

Reaching for the ‘White Spots’ in Rare Disease

September 27th 2023

Article

EU proposal focuses on a subset of underserved rare diseases—exploring the gaps in those conditions for which there is no approved treatment option.

The EU Regulations Catching US Pharma Companies Off Guard

September 25th 2023

Article

Companies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.

Audio Success in Pharma

September 15th 2023

Article

Panel at recent Talk Health event at Le Méridien, in Philadelphia, PA, on September 11th, 2023, focused on what success looks like in audio from a publisher, vendor, and HCP perspectives.

Speeding Up European Clinical Trials in Response to Emergencies

August 7th 2023

Article

With lessons from COVID now established, concrete ideas on improving drug development strategy for future health threats are beginning to take shape.

Implications of the U.S. Supreme Court’s Affirmative Action Ruling for Clinical Research

August 7th 2023

Article

If a future Supreme Court ruling on diversity were to be applicable to clinical research, the FDA’s positions on diversity will take on even more importance.

Related Content

FDA Inspections Face Continued Overhaul and Changes

October 13th 2023

Article

Agency will be reorganizing field force and compliance functions.

Reaching for the ‘White Spots’ in Rare Disease

September 27th 2023

Article

EU proposal focuses on a subset of underserved rare diseases—exploring the gaps in those conditions for which there is no approved treatment option.

The EU Regulations Catching US Pharma Companies Off Guard

September 25th 2023

Article

Companies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.

Audio Success in Pharma

September 15th 2023

Article

Panel at recent Talk Health event at Le Méridien, in Philadelphia, PA, on September 11th, 2023, focused on what success looks like in audio from a publisher, vendor, and HCP perspectives.

Speeding Up European Clinical Trials in Response to Emergencies

August 7th 2023

Article

With lessons from COVID now established, concrete ideas on improving drug development strategy for future health threats are beginning to take shape.

Implications of the U.S. Supreme Court’s Affirmative Action Ruling for Clinical Research

August 7th 2023

Article

If a future Supreme Court ruling on diversity were to be applicable to clinical research, the FDA’s positions on diversity will take on even more importance.